CRL Revenue 2026

Annual and quarterly sales data for Charles River Laboratories International Inc

Latest Annual Revenue

$4.05B

2024-12-28

YoY Growth

-1.9%

vs. previous year

4-Year CAGR

50.4%

compound growth

Annual Revenue History

2024-12-28

$4.05B

YoY Growth

-1.9%

2023-12-30

$4.13B

YoY Growth

+3.9%

2022-12-31

$3.98B

YoY Growth

+12.3%

2021-12-25

$3.54B

YoY Growth

+347.6%

2020-12-26

$791M

Quarterly Revenue Breakdown

2025-09-27

$1.00B

2025-06-28

$1.03B

2025-03-29

$984M

2024-09-28

$1.01B

2024-06-29

$1.03B

2024-03-30

$1.01B

2023-09-30

$1.03B

2023-07-01

$1.06B

Revenue by Segment

Total Revenue$4.05B (100.0%)

Get Full CRL Financial Analysis

View complete income statements, balance sheets, and AI-powered insights

Frequently Asked Questions

What is CRL's revenue?

CRL (Charles River Laboratories International Inc) reported $4.05 billion in revenue for 2024-12-28. This represents a 1.9% decrease compared to the previous year.

How much revenue does CRL make per year?

Charles River Laboratories International Inc generates approximately $4.05 billion in annual revenue based on the most recent fiscal year ending 2024-12-28.

Is CRL revenue growing?

CRL's revenue declined 1.9% year-over-year. This could be due to Health Care sector challenges, market conditions, or business restructuring.

What is CRL's quarterly revenue?

CRL reported $1.00 billion in revenue for the most recent quarter (2025-09-27).

What are CRL's revenue sources?

CRL's revenue comes from multiple segments: Total Revenue. See the revenue breakdown below for detailed segment analysis.

How does CRL compare to competitors in revenue?

CRL generates $4.05 billion in annual revenue in the Health Care sector. Compare CRL to competitors using our stock comparison tool to see relative market share and growth rates.

Disclaimer: Revenue data is based on publicly filed financial statements. Historical performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.

Explore Categories